• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病的计算机理论分子建模:神经保护和神经治疗中的尼古丁-姜黄素范例

In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy.

作者信息

Kumar Pradeep, Pillay Viness, Choonara Yahya E, Modi Girish, Naidoo Dinesh, du Toit Lisa C

机构信息

Department of Pharmacy and Pharmacology, University of the Witwatersrand, 7 York Road, Parktown, 2193, Johannesburg, South Africa; E-Mails:

出版信息

Int J Mol Sci. 2011 Jan 19;12(1):694-724. doi: 10.3390/ijms12010694.

DOI:10.3390/ijms12010694
PMID:21340009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3039975/
Abstract

The aggregation of the amyloid-β-peptide (AβP) into well-ordered fibrils has been considered as the key pathological marker of Alzheimer's disease. Molecular attributes related to the specific binding interactions, covalently and non-covalently, of a library of compounds targeting of conformational scaffolds were computed employing static lattice atomistic simulations and array constructions. A combinatorial approach using isobolographic analysis was stochastically modeled employing Artificial Neural Networks and a Design of Experiments approach, namely an orthogonal Face-Centered Central Composite Design for small molecules, such as curcumin and glycosylated nornicotine exhibiting concentration-dependent behavior on modulating AβP aggregation and oligomerization. This work provides a mathematical and in silico approach that constitutes a new frontier in providing neuroscientists with a template for in vitro and in vivo experimentation. In future this could potentially allow neuroscientists to adopt this in silico approach for the development of novel therapeutic interventions in the neuroprotection and neurotherapy of Alzheimer's disease. In addition, the neuroprotective entities identified in this study may also be valuable in this regard.

摘要

淀粉样β肽(AβP)聚集成有序的纤维被认为是阿尔茨海默病的关键病理标志物。利用静态晶格原子模拟和阵列构建,计算了与靶向构象支架的化合物库的特异性结合相互作用(共价和非共价)相关的分子属性。采用人工神经网络和实验设计方法(即针对小分子的正交面心中心复合设计,如姜黄素和糖基化去甲烟碱,它们在调节AβP聚集和寡聚方面表现出浓度依赖性行为),对使用等效线图分析的组合方法进行了随机建模。这项工作提供了一种数学和计算机模拟方法,为神经科学家提供了体外和体内实验的模板,构成了一个新的前沿领域。未来,这可能会使神经科学家采用这种计算机模拟方法来开发针对阿尔茨海默病神经保护和神经治疗的新型治疗干预措施。此外,本研究中鉴定出的神经保护实体在这方面可能也很有价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/967d5c3d3e7b/ijms-12-00694f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/c8d5dd444f12/ijms-12-00694f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/5a8f093cab3d/ijms-12-00694f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/f7112b22741b/ijms-12-00694f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/05e973296de3/ijms-12-00694f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/4206dc1b456b/ijms-12-00694f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/241a3d140bfd/ijms-12-00694f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/47c8b6aac737/ijms-12-00694f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/d13a94f513e8/ijms-12-00694f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/0f87978672f7/ijms-12-00694f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/edade3424ec0/ijms-12-00694f10a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/184b47df1b63/ijms-12-00694f11a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/8ea2c14e8d40/ijms-12-00694f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/11c1e86f3931/ijms-12-00694f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/f7ee24e74f60/ijms-12-00694f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/967d5c3d3e7b/ijms-12-00694f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/c8d5dd444f12/ijms-12-00694f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/5a8f093cab3d/ijms-12-00694f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/f7112b22741b/ijms-12-00694f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/05e973296de3/ijms-12-00694f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/4206dc1b456b/ijms-12-00694f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/241a3d140bfd/ijms-12-00694f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/47c8b6aac737/ijms-12-00694f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/d13a94f513e8/ijms-12-00694f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/0f87978672f7/ijms-12-00694f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/edade3424ec0/ijms-12-00694f10a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/184b47df1b63/ijms-12-00694f11a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/8ea2c14e8d40/ijms-12-00694f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/11c1e86f3931/ijms-12-00694f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/f7ee24e74f60/ijms-12-00694f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8981/3039975/967d5c3d3e7b/ijms-12-00694f15.jpg

相似文献

1
In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy.阿尔茨海默病的计算机理论分子建模:神经保护和神经治疗中的尼古丁-姜黄素范例
Int J Mol Sci. 2011 Jan 19;12(1):694-724. doi: 10.3390/ijms12010694.
2
Glycation of the amyloid beta-protein by a nicotine metabolite: a fortuitous chemical dynamic between smoking and Alzheimer's disease.一种尼古丁代谢物对β-淀粉样蛋白的糖基化作用:吸烟与阿尔茨海默病之间偶然的化学动力学关系
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8182-7. doi: 10.1073/pnas.1332847100. Epub 2003 Jun 18.
3
Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer's Disease.计算评估姜黄素衍生物与淀粉样β单体和纤维之间的相互作用:与阿尔茨海默病的相关性。
J Alzheimers Dis. 2021;82(s1):S321-S333. doi: 10.3233/JAD-200941.
4
Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids.姜黄素在健康与疾病中的应用:阿尔茨海默病与姜黄素类似物、衍生物和杂合物。
Int J Mol Sci. 2020 Mar 13;21(6):1975. doi: 10.3390/ijms21061975.
5
PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer's Disease.基于 PLGA 的姜黄素递药系统:阿尔茨海默病治疗的一种有前途的治疗方法。
Curr Neuropharmacol. 2022;20(2):309-323. doi: 10.2174/1570159X19666210823103020.
6
Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's Disease.基于分子动力学模拟和力学的配体与Aβ42相互作用机制的见解:共同结合位点在阿尔茨海默病药物设计中的作用启示
Chem Biol Drug Des. 2015 Oct;86(4):805-12. doi: 10.1111/cbdd.12555. Epub 2015 Mar 28.
7
Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?为何针对β淀粉样蛋白的研究未能为阿尔茨海默病带来新药?
ACS Chem Neurosci. 2017 Jul 19;8(7):1435-1437. doi: 10.1021/acschemneuro.7b00188. Epub 2017 Jun 6.
8
Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffold.通过姜黄素支架的定制功能化靶向阿尔茨海默病的多方面神经毒性。
Eur J Med Chem. 2023 Apr 5;252:115297. doi: 10.1016/j.ejmech.2023.115297. Epub 2023 Mar 21.
9
Prenylated Curcumin Analogues as Multipotent Tools To Tackle Alzheimer's Disease.姜黄素类化合物作为多效工具治疗阿尔茨海默病。
ACS Chem Neurosci. 2019 Mar 20;10(3):1420-1433. doi: 10.1021/acschemneuro.8b00463. Epub 2019 Jan 2.
10
Development of curcumin-based amyloid β aggregation inhibitors for Alzheimer's disease using the SAR matrix approach.基于 SAR 矩阵方法开发用于治疗阿尔茨海默病的姜黄素类淀粉样β聚集抑制剂。
Bioorg Med Chem. 2021 Sep 15;46:116357. doi: 10.1016/j.bmc.2021.116357. Epub 2021 Aug 8.

引用本文的文献

1
Research models to study lewy body dementia.用于研究路易体痴呆的研究模型。
Mol Neurodegener. 2025 Apr 23;20(1):46. doi: 10.1186/s13024-025-00837-w.
2
α-Synuclein in traumatic and vascular diseases of the central nervous system.α-突触核蛋白在中枢神经系统创伤性和血管性疾病中的作用。
Aging (Albany NY). 2020 Nov 7;12(21):22313-22334. doi: 10.18632/aging.103675.
3
Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells.

本文引用的文献

1
Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation.氨基酸修饰聚苯乙烯纳米粒子对淀粉样β蛋白纤维形成的双重影响。
ACS Chem Neurosci. 2010 Apr 21;1(4):279-87. doi: 10.1021/cn900027u. Epub 2010 Jan 27.
2
Why pleiotropic interventions are needed for Alzheimer's disease.为何阿尔茨海默病需要多效干预。
Mol Neurobiol. 2010 Jun;41(2-3):392-409. doi: 10.1007/s12035-010-8137-1. Epub 2010 May 2.
3
REVIEW: Curcumin and Alzheimer's disease.综述:姜黄素与阿尔茨海默病。
小花糖芥素白蛋白纳米粒对表皮生长因子受体过表达的胰腺癌细胞增强细胞毒性潜力的研究进展及作用机制洞察
Cancers (Basel). 2019 Nov 5;11(11):1733. doi: 10.3390/cancers11111733.
4
Characterization and Validation of Albiziasaponin-A, Iso-Orientin, and Salvadorin Using a Rat Model of Alzheimer's Disease.使用阿尔茨海默病大鼠模型对合欢皂苷-A、异荭草素和萨尔瓦多灵进行表征与验证
Front Pharmacol. 2018 Aug 2;9:730. doi: 10.3389/fphar.2018.00730. eCollection 2018.
5
Hypothesis: apo-lactoferrin-Galantamine Proteo-alkaloid Conjugate for Alzheimer's disease Intervention.假说:载脂蛋白-姜黄素-Galantamine 蛋白碱结合物用于阿尔茨海默病干预。
J Cell Mol Med. 2018 Mar;22(3):1957-1963. doi: 10.1111/jcmm.13484. Epub 2018 Jan 29.
6
A Hybrid Methacrylate-Sodium Carboxymethylcellulose Interpolyelectrolyte Complex: Rheometry and Disposition for Controlled Drug Release.一种甲基丙烯酸酯-羧甲基纤维素钠混合聚电解质复合物:流变学及控释药物的处置
Materials (Basel). 2013 Sep 26;6(10):4284-4308. doi: 10.3390/ma6104284.
7
A Dual-Biotic System for the Concurrent Delivery of Antibiotics and Probiotics: In Vitro, Ex Vivo, In Vivo and In Silico Evaluation and Correlation.双菌共生系统用于同时递送抗生素和益生菌:体外、离体、体内和计算评价及相关性。
Pharm Res. 2016 Dec;33(12):3057-3071. doi: 10.1007/s11095-016-2030-1. Epub 2016 Sep 6.
8
In silico design and analysis of a new hyperglycosylated analog of erythropoietin to improve drug efficacy.促红细胞生成素新型高糖基化类似物的计算机辅助设计与分析以提高药物疗效
Adv Biomed Res. 2015 Jul 27;4:142. doi: 10.4103/2277-9175.161548. eCollection 2015.
9
A Co-blended Locust Bean Gum and Polymethacrylate-NaCMC Matrix to Achieve Zero-Order Release via Hydro-Erosive Modulation.一种刺槐豆胶与聚甲基丙烯酸酯 - 羧甲基纤维素钠共混基质,通过水蚀调节实现零级释放。
AAPS PharmSciTech. 2015 Dec;16(6):1377-89. doi: 10.1208/s12249-015-0326-9. Epub 2015 May 9.
10
In vitro, ex vivo and in silico mechanistic elucidation of the performance of an optimized porosity-controlled multi-elemental transbuccal system.优化孔隙率控制的多元素经颊给药系统性能的体外、离体和计算机模拟机制阐释
Pharm Res. 2015 Jul;32(7):2384-409. doi: 10.1007/s11095-015-1631-4. Epub 2015 Jan 29.
CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x.
4
Nicotine increases the expression of neurotrophin receptor tyrosine kinase receptor A in basal forebrain cholinergic neurons.尼古丁增加基底前脑胆碱能神经元中神经营养因子受体酪氨酸激酶受体 A 的表达。
Neuroscience. 2010 Mar 17;166(2):580-9. doi: 10.1016/j.neuroscience.2009.12.073. Epub 2010 Jan 4.
5
Neuroscience: Alzheimer's disease.神经科学:阿尔茨海默病
Nature. 2009 Oct 15;461(7266):895-7. doi: 10.1038/461895a.
6
Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.常见神经退行性疾病的分子发病机制和临床治疗学的研究进展。
Int J Mol Sci. 2009 Jun 3;10(6):2510-2557. doi: 10.3390/ijms10062510.
7
Neurodegenerative disorders and nanoformulated drug development.神经退行性疾病与纳米制剂药物研发。
Nanomedicine (Lond). 2009 Jul;4(5):541-55. doi: 10.2217/nnm.09.37.
8
Neuroscience: The plaque plan.神经科学:斑块计划。
Nature. 2008 Nov 13;456(7219):161-4. doi: 10.1038/456161a.
9
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.聚集的小分子抑制剂表明,淀粉样β寡聚化和纤维化途径是独立且不同的。
J Biol Chem. 2007 Apr 6;282(14):10311-24. doi: 10.1074/jbc.M608207200. Epub 2007 Feb 6.
10
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.神经退行性变中的可溶性蛋白质寡聚体:来自阿尔茨海默病淀粉样β肽的启示
Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12. doi: 10.1038/nrm2101.